Kaye Mark's Form 4 filing
Elevance Health, Inc. (ELV) · filed Apr 25, 2025
- Accession no.
- 0001156039-25-000060
- Filed
- Apr 25, 2025
- Trade date
- Apr 24, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $1.95M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kaye MarkCIK 0001748691 | Officer (EVP & CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 24, 2025 | Common Stock | SSaleDisposed | −4,588 | $424.82F1 | −$1,949,074.16 | 18,977 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades, each at the same price of $424.82.
Referenced by the price of 1 transaction in Table I.